Search Results - "Belova, Yu. A."

Osmotic demyelination syndrome: central pontine and extrapontine myelinolysis in a patient in the early postpartum period. Clinical observation by Isakova, E. V., Stepanova, E. A., Kotov, S. V., Belova, Yu. A.

“…The article presents a review of the literature and a description of a clinical case of osmotic demyelination syndrome manifested by pontine and extrapontine…”
Get full text

Restoration of Speech Functions in Patients with Aphasia in the Early Rehabilitation Period of Ischemic Stroke by Kotov, S. V., Belova, Yu. A., Shcherbakova, M. M., Chervinskaya, A. D., Isakova, E. V., Volchenkova, T. V.

“…Objectives. To study the efficacy of complex therapy including daily speech therapy and two courses of Cellex in patients with aphasia in the early recovery…”
Get full text

Analysis of the clinical experience with perampanel in the Moscow Region: Efficacy, tolerability, individual choice priorities by Rudakova, I. G., Belova, Yu. A.

“…Objective: to analyze our clinical experience with perampanel (PER), by evaluating the efficacy, tolerability, and individual choice priorities.Patients and…”
Get full text

A Comparative Placebo-Controlled Clinical Trial of the Efficacy and Safety of Glatiramer Acetate 20 mg in Patients with Remitting Multiple Sclerosis: First-Year Study Results by Boiko, A. N., Lashch, N. Yu, Sharanova, S. N., Zakharova, M. N., Trifonova, O. V., Simaniv, T. O., Lysogorskaya, E. V., Gur’yanova, O. E., Kotov, S. V., Yakushina, T. I., Lizhdvoi, V. Yu, Belova, Yu. A., Khabirov, F. A., Babicheva, N. N., Khaibullin, T. I., Granatov, E. V., Aver’yanova, L. A., Sazonov, D. V., Odinak, M. M., Trinitatskii, Yu. V., Tsukurova, L. A., Sergeeva, A. I., Ivanov, R. A., Shustova, M. S.

“…Objective. To seek evidence that Timexon (BCD-063, glatiramer acetate, Biocad, Russia) and Copaxone-Teva (Teva Pharmaceuticals Ltd., Israel) have similar…”
Get full text

Antioxidant therapy in the complex treatment of patients with ischemic stroke in the acute and recovery period by Belova, Yu. A., Kotov, S. V.

“…Improvement of therapy of patients with ischemic stroke (IS) remains a relevant problem, despite the widespread use of drug and mechanical revascularization…”
Get full text

Use of Generic Medicines in the Treatment of Epilepsy Using Topiramate as an Example by Rudakova, I. G., Kotov, A. S., Belova, Yu. A.

“…Quantitative analysis of the causes of termination of pharmaceutical remission lasting more than one year was undertaken in 220 adult patients with epilepsy…”
Get full text

Management of patients with decompensation of epilepsy by Yu. A. Belova

“…Status epilepticus (SE) is a medical emergency when a seizure lasts without a breach of continuity or when seizures occur close together. The International…”
Get full text

Comment on "To solve the problem of driving a car in epilepsy: by liberalization or by tightening the license?" by Yu. A. Belova

Get full text

Psychotic disorders in multiple sclerosis by Yakushina, T I, Belova, Yu A

“…Nowadays there is no definite answer to questions: either multiple sclerosis (MS) patients with psychotic disorders have two independent diseases (multiple…”
Get more information

A retrospective analysis of using zonisamide and retention in monotherapy among patients with epilepsy in routine clinical practice by Rudakova, I G, Belova, Yu A, Kotov, A S, Romanova, M V

“…Zonisamide is one of the first antiepileptic drugs of new generation with a wide spectrum of action. It is successfully used in treatment of epilepsy for 30…”
Get more information

Efficiency of epilepsy treatment in the Moscow Region under the present-day conditions of drug provision by Rudakova, Irina Gennadyevna, Belova, Yu. A.

“…Objective: to evaluate the efficiency of epilepsy therapy in the two periods 2006–2007 and 2013–2014 due to drug provision-related changes: the use of…”
Get full text

New possibilities of monotherapy of symptomatic and cryptogenic partial epilepsy by Rudakova, I G, Belova, Yu A

“…This literature review is devoted to the use of the antiepileptic drug zonisamide in the initial monotherapy of symptomatic and cryptogenic partial epilepsy…”
Get more information

PSEUDOTUMORAL FORM OF MULTIPLE SCLEROSIS WITH SYMPTOMATIC CONVULSIVE SEIZURES (A CLINICAL CASE) by Belova, Yu. A., Yakushina, T. I., Rudakova, I. G.

“…Multiple sclerosis (MS) is prominent among central nervous system diseases. It affects chiefly young people and almost inevitably results in disability. In the…”
Get full text

Restoring of the speech functions in patients with aphasia in the early rehabilitation period of ischemic stroke by Kotov, S V, Belova, Yu A, Shcherbakova, M M, Chervinskaya, A D, Isakova, E V, Volchenkova, T V

“…To study the efficacy of combined therapy including daily sessions and two 10-day injections of the drug cellex in patients with aphasia in the early…”
Get more information

The efficacy of cocarnit in diabetic neuropathy by Kotov, S V, Isakova, E V, Leidvoll, V Yu, Belova, Yu A, Volchenkova, T V, Borodin, A V, Shvedov, V A

“…To study the efficacy of the complex therapy, including cocarnit (group B vitamins, triphosadenine and nicotinamide), of diabetic neuropathy. Forty-one…”
Get more information

The efficacy of systemic thrombolysis in patients with cardioembolic stroke by Kotov, S V, Isakova, E V, Belova, Yu A, Zmislinskiy, A V, Kolchu, I G, Kucheryavaya, M V, Pustinnikov, Ya A, Smetana, L V, Sashin, V V, Chernih, N P

“…To compare the efficacy and safety of systemic thrombolytic therapy (STLT) in patients with cardioembolic stroke (CE) versus other pathogenic subtypes of…”
Get more information

Diabetic asymmetric proximal neuropathy by Kotov, S V, Rudakova, I G, Isakova, E V, Belova, Yu A, Volchenkova, T V, Khirbek, M, Stashuk, G A

“…To study the prevalence, clinical features and treatment of diabetic asymmetric proximal neuropathy (DAPN). Four hundred and forty-five patients with diabetes…”
Get more information

A COMPARATIVE ANALYSIS OF EFFICACY OF INTERFERON BETA 1-B AND NATALIZUMAB TREATMENT IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS by Yakushina, T. I., Kotov, S. V., Yakushin, M. A., Belova, Yu. A., Kuchina, N. V., Andryukhina, O. M.

“…Background: Disease modifying drugs for multiple sclerosis have similar indications for use and at the same time, their specifics of the effect on the…”
Get full text

Epilepsy in patients with multiple sclerosis: specific features of diagnosis and therapy by Belova, Yu. A., Yaukushina, T. I., Rudakova, I. G., Kotov, S. V.

“…Once the symptoms of multiple sclerosis (MS) occur, the risk of developing epilepsy within 5 years is 1.1%; this indicator doubles and triples 10 and 15 years…”
Get full text

LEVELS OF ENDOTHELIAL PROGENITOR CELLS IN PATIENTS WITH ISCHEMIC STROKE AND EFFICACY OF REHABILITATION by Belova, Yu. A., Chuksina, Yu. Yu, Shevelev, S. V., Yazdovskiy, V. V., Kotov, S. V.

“…Background: Early diagnosis of stroke, its treatment and rehabilitation are considered priorities in the state health care policy. Pharmacological intervention…”
Get full text